Clinical Efficacy and Safety of Robot-assisted Total Knee Arthroplasty
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 80 years old?
Source: NCT06856356, who can take part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- The First Affiliated Hospital of University of Science and Technology of China
- Trial code
- NCT06856356
- Record updated
- 4 March 2025
- Original description
The purpose of this clinical trial is to understand the application value of the Orthopedic Joint Surgery Navigation System in assisting surgeons to accurately place prosthetic components in adult knee replacement surgery. It will also confirm its effectiveness and safety in clinical application.Read full original descriptionShow less
Comparison of Clinical Efficacy and Safety of Robot-assisted Total Knee Arthroplasty and Conventional Total Knee Arthroplasty: a Randomized Controlled Study
The purpose of this clinical trial is to understand the application value of the Orthopedic Joint Surgery Navigation System in assisting surgeons to accurately place prosthetic components in adult knee replacement surgery. It will also confirm its effectiveness and safety in clinical application.
Inclusion: Subjects voluntarily participate in the trial and sign the informed consent form; Aged 18 to 80 years old (inclusive), regardless of gender; Patients who need total knee replacement surgery; Those who can communicate well with the researchers and comply with the trial requirements.
Exclusion: Patients with general conditions or concomitant diseases that make it difficult for people to tolerate surgery; Patients with insufficient skin coverage near the surgical site and intolerance to surgery; Patients with metal implants in the joint surgical area that affect the execution of the surgical plan; Patients with alcohol dependence or drug addiction; Patients who are allergic to the drugs used in this trial or the implant materials; Patients with active infection; Patients with severe epilepsy or mental illness; Patients with severe coagulation disorders; Patients with immature bone development; Patients with neuropathy of the knee joint; Patients with poor bone quality that is not conducive to prosthesis fixation; Patients with insufficient quadriceps muscle strength; Patients with severe femoral or tibial deformities and other severe deformities outside the joint; Pregnant or lactating women; Patients who have participated in or are participating in other clinical trials within one month of enrollment; Patients who are considered by the researchers to be unsuitable for participating in this clinical trial for other reasons. Those who meet any of the above exclusion criteria need to be excluded.